Porcine Placenta Therapy
Extracted from porcine placenta | Contains EGF, FGF, IGF-1, TGF-β1
About This Treatment
Porcine placenta therapy injects porcine placental extracts into skin. Porcine placenta's genetic sequence is closest to human, offering high affinity. Abundantly contains EGF, FGF, IGF-1, TGF-β1, particularly excelling at wrinkle depth and width reduction.
Porcine placenta contains more growth factors than sheep, expecting stronger skin regeneration. Widely used in Asia (especially Japan, Korea) with established safety/efficacy. Animal-origin advantage includes relatively low cost for patient economy.
Mechanism of Action
Porcine placenta factors (EGF, FGF, IGF-1, TGF-β1) act on dermal fibroblasts. Growth factor receptors activate, triggering MAPK and PI3K/Akt cascades. Collagen I synthesis gene (COL1A1) upregulates, producing new collagen massively. Simultaneously, MMP-1 and MMP-2 expression decreases, inhibiting collagen degradation. Wrinkle depth and width reduce.
Indications
Expected Results
Post-porcine placenta injection, wrinkle depth decreases. Initial improvement at 2-4 weeks, significant improvement at 3-6 months. Wrinkle width narrows, skin smoothness improves. Rich clinical experience in Asia.
Clinical Evidence
Risks & Side Effects
Allergic reaction (animal protein). Rare prion infection risk. Infection risk minimal. Ethical and religious concerns regarding animal-derived products.
Interested in this treatment?
Start with an AI skin analysis to check your current skin condition